1035 Cambridge Street
Suite 18A
Cambridge, MA 02141
United States
212 582 1199
https://eternatx.com
版塊: Healthcare
行業: Biotechnology
全職員工: 8
名稱 | 頭銜 | 支付 | 行使價 | 出生年份 |
---|---|---|---|---|
Ms. Sandra M. Gurrola | Principal Financial & Accounting Officer and Senior VP of Finance | 305.88k | 無 | 1967 |
Mr. Sanjeev Luther | CEO, President & Director | 無 | 無 | 1962 |
Ms. Dorothy J. Clarke | General Counsel & Director | 無 | 無 | 1966 |
Eterna Therapeutics Inc., a life science company, provides mRNA cell engineering technologies. Its technologies include mRNA cell reprogramming and gene editing; NoveSlice and UltraSlice gene-editing proteins; and the ToRNAdo mRNA delivery system. The company has a license agreement with Factor Bioscience Limited. Eterna Therapeutics Inc. was founded in 2018 and is based in Cambridge, Massachusetts.
截至 無 止,Eterna Therapeutics Inc. 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中:無;董事會:無;股東權利:無;現金賠償:無。